![Peter Persigehl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Persigehl
Vorstandsvorsitzender bei Eurofins Genomics Europe Synthesis GmbH
Profil
Peter Persigehl currently works at Eurofins Genomics Europe Synthesis GmbH, as Co-Managing Director, Eurofins Genomics Europe Sequencing GmbH, as Co-Managing Director, Proteros biostructures GmbH, as Chief Operating Officer, Eurofins Genomics Germany GmbH, as Chief Operating Officer, and Eurofins LifeCodexx GmbH, as Member-Supervisory Board.
Aktive Positionen von Peter Persigehl
Unternehmen | Position | Beginn |
---|---|---|
Eurofins Genomics Europe Sequencing GmbH
![]() Eurofins Genomics Europe Sequencing GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Genomics Europe Sequencing GmbH provides technical, physical and chemical analysis services. The company is based in Konstanz, Germany. The CEOs are Andreas Hinkel, Thomas Brefort. The German company was founded in 2018. | Geschäftsführer | - |
Eurofins Genomics Germany GmbH
![]() Eurofins Genomics Germany GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Genomics Germany GmbH is a leading genomics services provider worldwide. The company is based in Ebersberg, Germany. Eurofins Genomics offers various platforms for genotyping, as well as genomic services such as NGS, gene expression, sanger sequencing, oligonucleotides, and gene synthesis. The German company also provides biomarker discovery services for disease diagnostics and therapeutic targets. Eurofins Genomics also offers SARS-CoV-2 research support. The company was founded in 1990, and Michael Hadem has been the CEO of the company since 2016. | Geschäftsführer | - |
Eurofins LifeCodexx GmbH
![]() Eurofins LifeCodexx GmbH BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins LifeCodexx GmbH is a German company that engages in research and development services. The company is based in Konstanz, Germany. | Direktor/Vorstandsmitglied | - |
Eurofins Genomics Europe Synthesis GmbH
![]() Eurofins Genomics Europe Synthesis GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Genomics Europe Synthesis GmbH engages in research and development services. The company is based in Ebersberg, Germany. The CEOs of the German company are Peter Persigehl, Mandy Deimel, Sonja Wiedemann. | Vorstandsvorsitzender | - |
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |
Eurofins Genomics Europe Synthesis GmbH
![]() Eurofins Genomics Europe Synthesis GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Genomics Europe Synthesis GmbH engages in research and development services. The company is based in Ebersberg, Germany. The CEOs of the German company are Peter Persigehl, Mandy Deimel, Sonja Wiedemann. | Commercial Services |
Eurofins Genomics Europe Sequencing GmbH
![]() Eurofins Genomics Europe Sequencing GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Genomics Europe Sequencing GmbH provides technical, physical and chemical analysis services. The company is based in Konstanz, Germany. The CEOs are Andreas Hinkel, Thomas Brefort. The German company was founded in 2018. | Commercial Services |
Eurofins LifeCodexx GmbH
![]() Eurofins LifeCodexx GmbH BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins LifeCodexx GmbH is a German company that engages in research and development services. The company is based in Konstanz, Germany. | Health Technology |
Eurofins Genomics Germany GmbH
![]() Eurofins Genomics Germany GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Genomics Germany GmbH is a leading genomics services provider worldwide. The company is based in Ebersberg, Germany. Eurofins Genomics offers various platforms for genotyping, as well as genomic services such as NGS, gene expression, sanger sequencing, oligonucleotides, and gene synthesis. The German company also provides biomarker discovery services for disease diagnostics and therapeutic targets. Eurofins Genomics also offers SARS-CoV-2 research support. The company was founded in 1990, and Michael Hadem has been the CEO of the company since 2016. | Commercial Services |